Table 1: Demographic characteristics of the study participants.

Total Wedge Group Curved Group P Value
Number of patients 15 12 3
Number of hips 18 14 4
Sex (male, female) 2, 16 2, 12 0, 4 0.043
Follow-up period, months
(mean ± SD, range)
72.2 ± 11.1,
54-91
70.1 ± 11.6,
54-91
79.5 ± 5.0,
72-84
0.143
Body weight, kg
(mean ± SD, range)
57.8 ± 15.3,
42.0-103.9
58.3 ± 16.7,
42-103.9
55.8 ± 10.8,
49.7-72.0
0.780
Body height, cm
(mean ± SD, range)
152.7 ± 7.3,
144.0-172.3
152.6 ± 5.6,
144.0-163.0
152.9 ± 12.9,
145.7-172.3
0.969
BMI, kg/m2
(mean ± SD, range)
24.6 ± 5.0,
19.5-39.1
24.8 ± 5.7,
19.5-39.1
23.7 ± 0.7,
23.1-24.4
0.495
Age at THA, years
(mean ± SD, range)
56 ± 11,
25-74
57.1 ± 11.8,
25-74
52.8 ± 0.5,
52-53
0.485
Age at osteotomy, years
(mean ± SD, range)
27.1 ± 10.8,
10-46
27.0 ± 11.6,
10-46
27.3 ± 9.1,
14-35
0.969
Duration after osteotomy, years (mean ± SD, range) 29.1 ± 9.0,
11-51
30.1 ± 9.0,
11-51
25.5 ± 9.4,
17-39
0.386
Osteotomy at pelvic side, n (%) 2 (11%) 1(7%) 1(25%) 0.316
Remaining implants, n (%) 5 (28%) 5 (36%) 0(0%) 0.160
Crowe classification Grade 1 7 6 1
                                  Grade 2 6 4 2
                                  Grade 3 3 2 1
                                  Grade 4 2 2 0

THA: total hip arthroplasty
SD: standard deviation